Clinical Trial Update: A Study of ONO-1110 in Patients With Major Depressive Disorder [Phase 2]

View source ↗

Summary

Clinical trial update indicates Ono Pharmaceutical's ONO-1110 is in Phase 2 testing for major depressive disorder and is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• ONO-1110

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Major Depressive Disorder (MDD | Phase 2 | Status: ACTIVE_NOT_RECRUITING